resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
0361ea84-13bb-4f90-8f24-bbd01a81801e,SMBCi003-B,['Cell Line'],"The SMBCi003-B cell line is an induced pluripotent stem cell (iPSC) line derived from a 21-year-old female patient of Han Chinese ethnicity with neurofibromatosis type 1 (NF1). The line carries a heterozygous c.496_497delGT mutation in the NF1 gene, resulting in a p.Val166LeufsTer7 frameshift variant.","['Cell line identity', 'Genetics']",,,,https://www.doi.org/10.1016/j.scr.2020.101842
0361ea84-13bb-4f90-8f24-bbd01a81801e,SMBCi003-B,['Cell Line'],"The SMBCi003-B iPSC line exhibited pluripotency by expressing stem cell markers like NANOG, OCT4, TRA-1-60, TRA-1-81, and alkaline phosphatase activity.","['Pluripotency', 'Marker expression']",,,,https://www.doi.org/10.1016/j.scr.2020.101842
0361ea84-13bb-4f90-8f24-bbd01a81801e,SMBCi003-B,['Cell Line'],"The SMBCi003-B line was able to differentiate into all three germ layers in vitro, demonstrating its trilineage differentiation potential.",['Differentiation potential'],,,,https://www.doi.org/10.1016/j.scr.2020.101842
